China Biologic Reports Financial Results for the Second Quarter and First Half of 2013
-- 2Q13 Total Sales Up 6.2% / 1H Total Sales Up 10.2% -- 2Q13 Operating Margin Up to 47.2% / 1H Operating Margin Up to 47.7% -- 2Q13 Non-GAAP Net Income Up 30.8% / 1H Non-GAAP Net Income Up 29.9% -- Agrees to Repurchase 1.48 Million Shares BEIJING, Aug. 7, 2013 /PRNewswire-Firs...
China Biologic Products Names Chairman David Gao to Additional Post of CEO
BEIJING, May 11, 2012 /PRNewswire-Asia-FirstCall/ China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that the Company's Board of Directors (the "Board") has ap...
China Biologic Products Reports Higher Results for the First Quarter 2012
BEIJING, May 8, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), today reported higher financial results for the three months en...
China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)
BEIJING, May 7, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that it will host its earnings conference call covering ...
China Biologic Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO
BEIJING and NEW YORK, April 27, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced the resignation of Chief Financial Offic...
China Biologic's Board Has Appointed Two New Independent Directors to Boost Corporate Governance
BEIJING, April 25, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that effective April 20, 2012, the Company's Board of...
China Biologic's Board Has Elected David (Xiaoying) Gao as the New Chairman and Has Adopted a Series of Measures to Enhance China Biologic's Corporate Governance
BEIJING, April 2, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that its Board of Directors has adopted a series of me...
China Biologic Receives SFDA Approval to Begin Clinical Trials for Human Fibrinogen
BEIJING, March 23, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that its indirectly owned subsidiary, Shandong Taiban...
China Biologic Products Reports Results for the Year 2011
BEIJING, March 12, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), today reported its financial results for the year ended Dece...
China Biologic to Host Earnings Conference Call on March 13, 2012 at 8:00 a.m. EDT (NY)
BEIJING, March 9, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in China, today announced that it will host an earnings conference call covering its year 2011 financial ...
China Biologic Reports Third Quarter 2011 Results
TAI'AN, China, Nov. 7, 2011 /PRNewswire-Asia-FirstCall/ -- *China Biologic Products, Inc.* (NASDAQ: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), today reported its financial results for the three and...
China Biologic to Host Earnings Conference Call on November 8, 2011 at 8:00 a.m. EST (NY)
BEIJING, Nov. 4, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in China, today announced that it will host an earnings conference call covering its third quarter 2011 fi...
China Biologic Nominated for the 2011 Scrip Award as Best Company in an Emerging Market
BEIJING, Oct. 28, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that it has been selected as a nominee for the 7th Ann...
China Biologic Named to Asia's "200 Best Under a Billion" by Forbes Asia
BEIJING, Oct. 24, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that it has been included in Forbes Magazine's annual ...
China Biologic Announces Changes in Directors
BEIJING and NEW YORK, Oct. 6, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced two changes in its board of directors. On...
China Biologic to Attend Jefferies Healthcare Conference on September 27 and 28, 2011 in London
BEIJING, Sept. 26, 2011 /PRNewswire-Asia-FirstCall/ China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that it will participate in the Jefferies 2011 Global He...
China Biologic Products to Present at UBS Global Life Sciences Conference on September 19
TAI'AN, China, Sept. 16, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will present at the UBS Global Life Sciences Conference in New York on Sept...
China Biologic Products Reports Second Quarter 2011 Results
TAI'AN, China, Aug. 9, 2011 /PRNewswire-Asia-FirstCall/ -- *China Biologic Products, Inc.* (NASDAQ: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), today reported its results for the three months ended ...
China Biologic Products to Host Earnings Conference Call on August 10, 2011 at 7:00 a.m. EDT (NY)
TAI'AN, China, Aug. 8, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host its earnings conference call covering its second quarter 2011 resu...
China Biologic's 2 Plasma Collection Stations in Guizhou Province Have Been Inspected and Relicensed, 4 Other Stations in Disallowed Counties Closed on August 1, 2011
TAI'AN, China, Aug. 1, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that 2 of its plasma collection stations, in Pu Ding and Huang Ping counties in the...
